RANDOMIZED PHASE II TRIAL OF NGR-HTNF AND CHEMOTHERAPY IN CHEMO-NAIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS.

被引：0
|
作者：
Gregorc, Vanesa [1 ]
Zilembo, N. [2 ]
Grossi, Francesco
Rossoni, Gilda [1 ]
Pietrantonio, Filippo [2 ]
Rijavec, Erika
Bulotta, Alessandra [1 ]
Vitali, Milena [2 ]
Barletta, Giulia
Bergamaschi, Luca [2 ]
Platania, Marco [2 ]
Lambiase, Antonio
Bordignon, Claudio
机构：
[1] Ist Sci San Raffaele, Dept Oncol, Milan, Italy
[2] Ist Nazl Tumori, Naples, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; Chemotherapy; NGR-hTNF;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S661 / S662
页数：2
相关论文
共 50 条
  • [21] A randomized phase II study of sequential carboplatin/paclitaxel (CP) and gefitinib (G) in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC): Preliminary results.
    Nokihara, H.
    Ohe, Y.
    Kawaishi, M.
    Kato, T.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 388S - 388S
  • [22] A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naive patients with non-small cell lung cancer harboring EGFR mutations
    Ninomiya, Takashi
    Ishikawa, Nobuhisa
    Kozuki, Toshiyuki
    Kuyama, Shoichi
    Inoue, Koji
    Yokoyama, Toshihide
    Kanaji, Nobuhiro
    Yasugi, Masayuki
    Shibayama, Takuo
    Aoe, Keisuke
    Ochi, Nobuaki
    Fujitaka, Kazunori
    Kodani, Masahiro
    Ueda, Yutaka
    Watanabe, Kazuhiko
    Bessho, Akihiro
    Sugimoto, Keisuke
    Oze, Isao
    Hotta, Katsuyuki
    Kiura, Katsuyuki
    LUNG CANCER, 2023, 184
  • [23] Apatinib in combination with pemetrexed-platinum chemotherapy for chemo-naive non-squamous non-small cell lung cancer: a phase II clinical study
    Yang, Guangjian
    Xu, Haiyan
    Yang, Lu
    Xu, Fei
    Zhang, Shuyang
    Yang, Yaning
    Wang, Yan
    LUNG CANCER, 2020, 147 : 229 - 236
  • [24] NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung Cancer
    Gregorc, Vanesa
    Cavina, Raffaele
    Novello, Sivia
    Grossi, Francesco
    Lazzari, Chiara
    Capelletto, Enrica
    Genova, Carlo
    Salini, Giulia
    Lambiase, Antonio
    Santoro, Armando
    ONCOLOGIST, 2018, 23 (10): : 1133 - +
  • [25] Phase II study of NGR-hTNF, a vascular targeting agent, in combination with doxorubicin in patients with relapsed small cell lung cancer (SCLC)
    Gregorc, V.
    Novello, S.
    Santoro, A.
    Grossi, F.
    Levra, M. Giaj
    Cavina, R.
    Vigano, M.
    Caligaris-Cappio, F.
    Lambiase, A.
    Bordignon, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] A GALICIAN LUNG CANCER GROUP PHASE II STUDY OF BEVACIZUMAB (B), CISPLATIN AND VINORELBINE IN CHEMO-NAIVE PATIENTS (P) WITH NON SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC)
    Areses Manrique, M. C.
    Vazquez Estevez, S.
    Gracia, J. M.
    Casal Rubio, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    Santome, L.
    Macia, S.
    Leon, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 145 - 145
  • [27] A phase II study of weekly irinotecan plus capecitabine for chemo-naive patients with advanced non-small cel lung cancer
    Han, J
    Lee, D
    Lee, S
    Park, C
    Kim, H
    Lee, H
    Lee, J
    Lee, J
    LUNG CANCER, 2005, 49 : S247 - S247
  • [28] Bevacizumab (B), Cisplatin and Vinorelbine in Chemo-Naive Patients (P) with Non Squamous Non Small Cell Lung Cancer (NSCLC): A Galician Lung Cancer Group Phase II study
    Vazquez, Sergio
    Leon, Luis
    Gracia, Jose M.
    Casal, Joaquin
    Lazaro, Martin
    Luis Firvida, Jose
    Amenedo, Margarita
    Santome, Lucia
    Macia, Sonia
    Alvarez, Elena
    Vicente Cardona, Jose
    Vazquez, Francisca
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S718 - S719
  • [29] Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study
    Vazquez, S.
    Leon, L.
    Gracia, J. M.
    Casal, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    Santome, L.
    Cardona, J. V.
    Macia, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 548 - 549
  • [30] Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naive patients with advanced non-small cell lung cancer
    Shimada, Temiko
    Satouchi, Miyako
    Kotani, Yoshikazu
    Katakami, Nobuyuki
    Urata, Yoshiko
    Yoshimura, Sho
    Funada, Yasuhiro
    Hata, Akito
    Ando, Masahiko
    Negoro, Shunichi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S451 - S451
12345